1.08212
Parteck® PLX 188 (Poloxamer 188)
(stabilized with 70ppm BHT), EMPROVE® ESSENTIAL, Ph. Eur., ChP, NF
別名:
Poloxamer 188
ログインで組織・契約価格をご覧ください。
サイズを選択してください
表示を変更する
この商品について
biological source
synthetic
Quality Level
agency
ChP, NF, Ph. Eur.
product line
EMPROVE® ESSENTIAL
bp
>150 °C
mp
55 °C
bulk density
1050 kg/m3
storage temp.
2-25°C
SMILES string
O2C(C2)C.O1CC1
InChI
1S/C3H6O.C2H4O/c1-3-2-4-3;1-2-3-1/h3H,2H2,1H3;1-2H2
InChI key
RVGRUAULSDPKGF-UHFFFAOYSA-N
General description
With formulation challenges in mind, we have used particle engineering technologies to develop functional excipients specifically for solid oral dosage forms. The products in our Parteck® portfolio feature unique particle properties tailored for excellent performance in tableting processes, for specific drug delivery technologies, or for solubility enhancement.
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.
Application
Parteck® PLX 188 excipient combines adequate lubrication at tolerable concentrations with the added benefit of dissolution enhancement. It features consistent performance, improved dissolution rate and reliable lubrication – all at the same time. As a result, Parteck® PLX 188 excipient can therefore provide a simple solution to low bioavailability of DCS 2a compounds.
Features and Benefits
- Hydrophilic, water-soluble tablet lubrication
- Improved dissolution rates for poorly soluble DCS class IIa molecules
- Specified particle size distribution optimized for solid application performance
- Regulatory support through compliance with Ph. Eur. and USP-NF, going beyond current requirements with specitied formaldehyde content
Legal Information
Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
PARTECK is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany
保管分類
11 - Combustible Solids
wgk
WGK 1
flash_point_f
>302.0 °F
flash_point_c
> 150 °C
Emprove®プログラムを使用してGMPを遵守します。
Emprove® Dossiersで資格認定を加速し、コンプライアンスを維持し、時間を節約しましょう。
Dossiers をダウンロード
注意: EmproveSuite.comに移動します。ユーザー名とパスワードはSigmaAldrich.comとは別のもので、異なる場合があります。
無料会員登録すると、数分でEmprove® Dossiersにアクセスできます。 購読プランをアップグレードして、Emprove® Suiteの高度でカスタマイズされたコンテンツをアンロックしてください。
お探しのものが見つかりませんか？Emprove® プログラムのヘルプページをご覧ください。.
資料
Our overview of API solubility and dissolution enhancement methods can help you decide between the many options to take during formulation.
グローバルトレードアイテム番号
| カタログ番号 | GTIN |
|---|---|
| 1.08212.9025 | 04061841048671 |
| 1.08212.0500 | 04061841048657 |
| 1.08212.0001 | 04061841048640 |